Artificial Intelligence | Tissuepathology.com

Join Indica Labs for Next Week’s Webinar

Erica Goodpaster — Fri, 06 Nov 2026 13:31:05 +0000

Indica Labs: Learn how HALO Link enables a centralized digital pathology workflow designed to support biomarker and translational research From Image to Insight: Automating Biomarker Research Workflows with HALO Link Date: 19 November 2026 Time: 8:00 – 9:00 EST | 13:00 – 14:00 GMT | 14:00 – 15:00 CET Location: Webinar Register Now Summary Digital […]

The post Join Indica Labs for Next Week’s Webinar first appeared on Tissuepathology.com.

Agilent Completes Acquisition of Proscia

Erica Goodpaster — Thu, 05 Nov 2026 13:12:24 +0000

Agilent: Expands Agilent’s pathology portfolio and establishes a platform for scientific intelligence in tissue-based precision medicine Strengthens Agilent’s ability to support customers across clinical diagnostics, biopharma and life-sciences research SANTA CLARA, Calif., November 04, 2026 — Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Proscia®, a leading […]

The post Agilent Completes Acquisition of Proscia first appeared on Tissuepathology.com.

Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab

Erica Goodpaster — Tue, 03 Nov 2026 13:08:57 +0000

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. commercial availability of the HyperVue Integrated System [1], a new single room-based configuration of its HyperVue Imaging System for DeepOCT+NIRS imaging and X1-FFR physiology assessment. It is designed to keep advanced coronary imaging and physiology tools […]

The post Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab first appeared on Tissuepathology.com.

Read the Latest Case Study From Indica Labs

Erica Goodpaster — Mon, 02 Nov 2026 13:33:50 +0000

From Indica Labs: As a leading provider of laboratory services in genomics, multiomics and healthcare diagnostics, Source BioScience is leveraging large-scale digital pathology to support over 90 partner NHS trusts. Interoperability and integration are critical at this scale, with customized LIMS and IMS plugins and Indica Labs’ HALO AP platform being key components of Source […]

The post Read the Latest Case Study From Indica Labs first appeared on Tissuepathology.com.

Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026

Erica Goodpaster — Fri, 30 Oct 2026 13:18:59 +0000

From Diagnexia on LinkedIn: Delighted to share that Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026. A huge congratulations to our incredible team and partners for driving innovation and excellence every day. Thank you to LaingBuisson for the recognition, and best of luck to all the nominees. […]

The post Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026 first appeared on Tissuepathology.com.

Indica Labs: In Situ Hybridization Publications with the HALO® Image Analysis Platform

Erica Goodpaster — Thu, 29 Oct 2026 13:02:57 +0000

From Indica Labs: For researchers using in situ hybridization, optimization of both probing conditions and the analysis approach is necessary for the clearest results, yet the process of identifying the best values can be time consuming. Targeting this challenge, Indica Labs has released a new publication list highlighting papers citing its collection of HALO image […]

The post Indica Labs: In Situ Hybridization Publications with the HALO® Image Analysis Platform first appeared on Tissuepathology.com.